8.2001

2.61% -0.2199

Nextcure Inc (NXTC)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt NXTC? Forum Prognose

Schlusskurs vom Vortag:

$8.42

Offen:

$8.57

24-Stunden-Volumen:

11,346

Relative Volume:

0.01

Marktkapitalisierung:

$37.53M

Einnahmen:

Nettoeinkommen (Verlust:

$-54.66M

KGV:

-0.4299

EPS:

-19.0729

Netto-Cashflow:

$-49.98M

1W Leistung:

+11.56%

1M Leistung:

+40.41%

6M Leistung:

-34.45%

1J Leistung:

+61.74%

1-Tages-Spanne:

$7.69

$8.57

1-Wochen-Bereich:

$7.05

$8.64

52-Wochen-Spanne:

$1.55

$15.74

Nextcure Inc Stock (NXTC) Company Profile

Firmenname

Nextcure Inc

Sektor

Healthcare (1087)

Branche

Biotechnology (606)

Telefon

240-399-4900

Adresse

9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD

Mitarbeiter

Twitter

@nextcureinc

Nächster Verdiensttermin

2026-08-06

Neueste SEC-Einreichungen

NXTC's Discussions on Twitter

Compare NXTC vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NXTC Nextcure Inc	8.20	38.54M	0	-54.66M	-49.98M	-19.07
VRTX Vertex Pharmaceuticals Inc	522.64	134.06B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	804.34	83.43B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,002.89	63.00B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	137.62	56.02B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	209.08	44.44B	742.00K	-1.37B	-1.07B	-7.0731

Nextcure Inc Stock (NXTC) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-07	Hochstufung	Ladenburg Thalmann	Neutral → Buy
2022-11-04	Herabstufung	Ladenburg Thalmann	Buy → Neutral
2022-03-01	Eingeleitet	Ladenburg Thalmann	Buy
2021-03-05	Hochstufung	Truist	Hold → Buy
2021-01-15	Herabstufung	BofA Securities	Neutral → Underperform
2020-07-16	Hochstufung	The Benchmark Company	Hold → Buy
2020-07-13	Herabstufung	ROTH Capital	Buy → Neutral
2020-07-13	Herabstufung	SunTrust	Buy → Hold
2020-06-01	Herabstufung	BofA/Merrill	Buy → Neutral
2020-06-01	Herabstufung	The Benchmark Company	Buy → Hold
2020-05-26	Eingeleitet	JMP Securities	Mkt Outperform
2020-03-24	Eingeleitet	The Benchmark Company	Buy
2020-03-02	Eingeleitet	ROTH Capital	Buy
2020-01-13	Eingeleitet	SunTrust	Buy
2019-12-05	Eingeleitet	Needham	Buy
2019-11-26	Eingeleitet	BTIG Research	Buy
2019-07-09	Eingeleitet	BofA/Merrill	Buy
2019-06-03	Eingeleitet	Morgan Stanley	Overweight
2019-06-03	Eingeleitet	Piper Jaffray	Overweight

Alle ansehen

Nextcure Inc Aktie (NXTC) Neueste Nachrichten

Sep 08, 2026

About 30,000 sq ft of lab as NextCure (NXTC) exits Maryland site—what it paid to leave early - Stock Titan

Sep 03, 2026

NextCure Enters Into Ninth Amendment To Lease Agreement And Vacates Premises At 8000 Virginia Manor Road - marketscreener.com

Sep 03, 2026

Aug 26, 2026

NextCure - The Pharma Letter

Aug 26, 2026

Aug 20, 2026

NextCure (NXTC) Q2 2026 Earnings: Profit Per Share Falls Below Its Benchmark for the Current Session - vinanet.vn

Aug 20, 2026

Aug 18, 2026

NextCure (NASDAQ: NXTC) plans Avere merger backed by $820M raise - Stock Titan

Aug 18, 2026

NextCure (NXTC) Share-Price Review: Declines 11.15% to $6.85 at the Close; Current Range Read: the Near-Term Reference Band Stretches From $6.51 to $7.19 under the Current SnapshotExtension Target - vinanet.vn

Aug 18, 2026

Aug 14, 2026

Ikarian Capital discloses 9.99% NextCure (NXTC) stake including large warrant position - Stock Titan

Aug 14, 2026

NextCure (NXTC) gains 15.8% beneficial owner in ADAR1 Capital and manager - Stock Titan

Aug 14, 2026

NextCure (NXTC): Squadron funds and partners disclose 1.6% equity stake - Stock Titan

Aug 14, 2026

Aug 13, 2026

Affinity Asset Advisors discloses 6.4% NextCure (NXTC) stake via stock and warrants - Stock Titan

Aug 13, 2026

NextCure stock rating reiterated at Buy by H.C. Wainwright - Investing.com

Aug 13, 2026

Aug 12, 2026

Major Former Stakeholder Makes a Significant Move in NextCure Stock - TipRanks

Aug 12, 2026

Simcere Zaiming sells $184,800 of NextCure stock By Investing.com - Investing.com India

Aug 12, 2026

Adage Capital files Schedule 13G showing 7.67% NextCure (NXTC) ownership - Stock Titan

Aug 12, 2026

Simcere Zaiming sells $184,800 of NextCure stock - Investing.com

Aug 12, 2026

Simcere group (NXTC) trims NextCure stake, ends 10% beneficial ownership - Stock Titan

Aug 12, 2026

RTW Biotech's Avere to go public in US in reverse merger with NextCure - London South East

Aug 12, 2026

Aug 11, 2026

RTW Biotech Opportunities (RTWG) Supports Avere Therapeutics’ $820M Capital Raise and NextCure Reverse Merger - Kalkine Media

Aug 11, 2026

Aug 10, 2026

NextCure (NXTC) plans reverse merger with Avere and $820M financings - Stock Titan

Aug 10, 2026

Xcellon Acquires 40,000 Sq ft Maryland Facility from NextCure to Deliver a cGMP-Ready CRDMO for ADCs - BioBuzz

Aug 10, 2026

Xcellon Biologics Acquires GMP Manufacturing Facility from NextCure, Becoming an End-to-End CRDMO for Next-Generation Bioconjugates and Complex Biologics - The Manila Times

Aug 10, 2026

Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001 - Nasdaq

Aug 10, 2026

Aug 09, 2026